MiR-205 Inhibits Neuroblastoma Growth by Targeting CAMP-Responsive Element-Binding Protein 1

Overview

Journal Oncol Res

Specialty Oncology

Date 2017 Jun 28

PMID 28653600

Citations 10

Authors

Shu Chen

Lianhua Jin

Shu Nie

Lizhi Han

Na Lu

Yan Zhou

Affiliations

Soon will be listed here.

Abstract

Accumulating evidence indicates that microRNA-205 (miR-205) is involved in tumor initiation, development, and metastasis in various cancers. However, its functions in neuroblastoma (NB) remain largely unclear. Here we found that miR-205 was significantly downregulated in human NB tissue samples and cell lines. miR-205 expression was lower in poorly differentiated NB tissues and those of advanced International Neuroblastoma Staging System stage. In addition, restoration of miR-205 in NB cells suppressed proliferation, migration, and invasion and induced cell apoptosis in vitro, as well as impaired tumor growth in vivo. cAMP-responsive element-binding protein 1 () was identified as a direct target gene of miR-205. Expression of an miR-205 mimic in NB cells significantly diminished expression of CREB1 and the CREB1 targets BCL-2 and MMP9. CREB1 was also found to be upregulated in human NB tissues, its expression being inversely correlated with miR-205 expression ( = -0.554, = 0.003). Importantly, CREB1 upregulation partially rescued the inhibitory effects of miR-205 on NB cells. These findings suggest that miR-205 may function as a tumor suppressor in NB by targeting .

Citing Articles

Role of non-coding RNAs in neuroblastoma.

Anoushirvani A, Jafarian Yazdi A, Amirabadi S, Ahmadi Asouri S, Shafabakhsh R, Sheida A Cancer Gene Ther. 2023; 30(9):1190-1208.

PMID: 37217790 DOI: 10.1038/s41417-023-00623-0.

Deciphering the Role of MicroRNAs in Neuroblastoma.

Veeraraghavan V, Jayaraman S, Rengasamy G, Mony U, Ganapathy D, Geetha R Molecules. 2022; 27(1).

PMID: 35011335 PMC: 8746473. DOI: 10.3390/molecules27010099.

A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.

Gamble L, Purgato S, Henderson M, Di Giacomo S, Russell A, Pigini P Cancers (Basel). 2021; 13(8).

PMID: 33918978 PMC: 8069650. DOI: 10.3390/cancers13081807.

miR-338-3p inhibits cell growth, invasion, and EMT process in neuroblastoma through targeting MMP-2.

Yuan H, Liu F, Ma T, Zeng Z, Zhang N Open Life Sci. 2021; 16(1):198-209.

PMID: 33817311 PMC: 7968531. DOI: 10.1515/biol-2021-0013.

Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Rezaei O, Tamizkar K, Hajiesmaeili M, Taheri M, Ghafouri-Fard S Front Oncol. 2021; 11:617362.

PMID: 33718173 PMC: 7945591. DOI: 10.3389/fonc.2021.617362.

References

Maroney P, Yu Y, Nilsen T . MicroRNAs, mRNAs, and translation. Cold Spring Harb Symp Quant Biol. 2007; 71:531-5. DOI: 10.1101/sqb.2006.71.043. View

Stallings R . MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics. Curr Pharm Des. 2009; 15(4):456-62. PMC: 2945477. DOI: 10.2174/138161209787315837. View

Mayr B, Montminy M . Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001; 2(8):599-609. DOI: 10.1038/35085068. View

Ying S, Chang D, Lin S . The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol Biotechnol. 2007; 38(3):257-68. PMC: 7091389. DOI: 10.1007/s12033-007-9013-8. View

Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

de Carvalho I, Freitas R, Vargas F . Translating microRNAs into biomarkers: What is new for pediatric cancer?. Med Oncol. 2016; 33(5):49. DOI: 10.1007/s12032-016-0766-4. View

Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb B, Chen D . miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun. 2014; 5:5671. PMC: 4377070. DOI: 10.1038/ncomms6671. View

Wang L, Shan M, Liu Y, Yang F, Qi H, Zhou L . miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA. Onco Targets Ther. 2015; 8:2635-42. PMC: 4577256. DOI: 10.2147/OTT.S80088. View

Orang A, Safaralizadeh R, Feizi M, Somi M . Diagnostic and prognostic value of miR-205 in colorectal cancer. Asian Pac J Cancer Prev. 2014; 15(9):4033-7. DOI: 10.7314/apjcp.2014.15.9.4033. View

10.

Zamarbide M, Etayo-Labiano I, Ricobaraza A, Martinez-Pinilla E, Aymerich M, Lanciego J . GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells. Hippocampus. 2014; 24(7):733-9. DOI: 10.1002/hipo.22263. View

11.

Li C, Wu W, Wu W, Liao Y, Chen L, Huang C . The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma. Oncotarget. 2015; 6(11):9220-39. PMC: 4496213. DOI: 10.18632/oncotarget.3312. View

12.

Elgamal O, Park J, Gusev Y, Azevedo-Pouly A, Jiang J, Roopra A . Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS One. 2013; 8(10):e76402. PMC: 3788717. DOI: 10.1371/journal.pone.0076402. View

13.

Guo J, Dong Q, Fang Z, Chen X, Lu H, Wang K . Identification of miRNAs that are associated with tumor metastasis in neuroblastoma. Cancer Biol Ther. 2010; 9(6):446-52. DOI: 10.4161/cbt.9.6.10894. View

14.

Lei L, Huang Y, Gong W . miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN. Oncol Rep. 2013; 30(6):2897-902. DOI: 10.3892/or.2013.2755. View

15.

Niu K, Shen W, Zhang Y, Zhao Y, Lu Y . MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1. Gene. 2015; 574(2):330-6. DOI: 10.1016/j.gene.2015.08.017. View

16.

Ni Y, Zhou Y, Zhou M, Zhang L . Akt and cAMP response element binding protein mediate 17β-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line. Neurosci Lett. 2015; 604:58-63. DOI: 10.1016/j.neulet.2015.07.041. View

17.

Zhang X, Odom D, Koo S, Conkright M, Canettieri G, Best J . Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A. 2005; 102(12):4459-64. PMC: 555478. DOI: 10.1073/pnas.0501076102. View

18.

Zhong G, Xiong X . miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression. Biol Res. 2015; 48:60. PMC: 4625464. DOI: 10.1186/s40659-015-0052-5. View

19.

Jin C, Liang R . miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells. J Obstet Gynaecol Res. 2015; 41(10):1653-60. DOI: 10.1111/jog.12756. View

20.

Calin G, Croce C . MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006; 66(15):7390-4. DOI: 10.1158/0008-5472.CAN-06-0800. View